EXOMIND (BTL-995) for Reduction of Binge-eating

NACompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

July 26, 2023

Primary Completion Date

December 15, 2023

Study Completion Date

March 11, 2024

Conditions
Binge-Eating Disorder
Interventions
DEVICE

Treatment with BTL-995-rTMS

Six transcranial magnetic stimulation treatments with the BTL-995-rTMS device will be delivered over the left dorsolateral prefrontal cortex, spaced 2 to 4 days apart. The intensity will be adjusted according to the subject's feedback, up to 70% of the individual's motor threshold.

Trial Locations (1)

1680

"Medical Center Intermedica", Sofia

All Listed Sponsors
lead

BTL Industries Ltd.

INDUSTRY